Education, Science, Technology, Innovation and Life
Open Access
Sign In
  1. Home
  2. Journals
  3. MEDS Clinical Medicine
  4. Vol 5, Issue 5, 2024

Research progress in the treatment of chronic subdural hematomas by embolisation of the middle meningeal artery

Download as PDF

DOI: 10.23977/medsc.2024.050504 | Downloads: 15 | Views: 350

Author(s)

Liu Lei 1, Zhang Yi 2

Affiliation(s)

1 Shaanxi University of Chinese Medicine, Xianyang, Shaanxi, 712000, China
2 Affiliated Hospital of Shaanxi University of Chinese Medicine, Xianyang, Shaanxi, 712000, China

Corresponding Author

Zhang Yi

ABSTRACT

CSDH is one of the common diseases in neurosurgery, and currently surgical treatment is the preferred treatment option for symptomatic CSDH, but the high rate of postoperative recurrence is still a major drawback of surgical treatment; in recent years, some studies have proved that the method of blocking the source of hematoma by EMMA is effective in the treatment of CSDH; therefore, this paper presents an overview of anatomical-pathophysiological bases, indications, and contraindications for the treatment of CSDH by EMMA, research progress of clinical embolization materials and embolization efficacy are reviewed.

KEYWORDS

Chronic subdural hematoma, middle meningeal artery embolization, research progress, review

CITE THIS PAPER

Liu Lei, Zhang Yi. Research progress in the treatment of chronic subdural hematomas by embolisation of the middle meningeal artery. MEDS Clinical Medicine (2024) Vol. 5: 23-28. DOI: http://dx.doi.org/10.23977/medsc.2024.050504.

REFERENCES

[1] FEGHALI J, YANG W, HUANG J. Updates in chronic subdural hematoma: epidemiology, etiology, pathogenesis, treatment, and outcome [J]. World neurosurgery, 2020, 141: 339-345.
[2] OU Y, DONG J, WU L, et al. The clinical characteristics, treatment, and outcomes of chronic subdural hematoma in young patients [J]. World Neurosurgery, 2019, 125: e1241-e1246. 
[3] KAN P, MARAGKOS G A, SRIVATSAN A, et al. Middle meningeal artery embolization for chronic subdural hematoma: a multi-center experience of 154 consecutive embolizations [J]. Neurosurgery, 2021, 88(2): 268-277.
[4] TAMURA R, SATO M, YOSHIDA K, et al. History and current progress of chronic subdural hematoma [J]. J Neurol Sci, 2021, 429: 118066.
[5] HU Kai, ZHANG Hua. Advances in the pathogenesis and treatment of chronic subdural hematoma [J]. Journal of Clinical Neurosurgery, 2024, 21(01): 102-5+9.
[6] SHAPIRO M, WALKER M, CARROLL K T, et al. Neuroanatomy of cranial dural vessels: implications for subdural hematoma embolization [J]. Journal of NeuroInterventional Surgery, 2021, 13(5): 471-477.
[7] SANTIAGO R B, JASTRZEBSKI C, DAKWAR E, et al. Middle meningeal artery embolization for chronic subdural hematoma-pathophysiology and radiological findings [J]. World Neurosurgery: X, 2024, 23: 100296.
[8] TEMPAKU A, YAMAUCHI S, IKEDA H, et al. Usefulness of interventional embolization of the middle meningeal artery for recurrent chronic subdural hematoma: Five cases and a review of the literature [J]. Interv Neuroradiol, 2015, 21(3): 366-371.
[9] IRONSIDE N, NGUYEN C, DO Q, et al. Middle meningeal artery embolization for chronic subdural hematoma: a systematic review and meta-analysis [J]. Journal of neurointerventional surgery, 2021, 13(10): 951-957.
[10] XUAN H D, MINH T P, VAN H D, et al. Preoperative middle meningeal artery embolization in the treatment of organized chronic subdural hematoma [J]. Radiol Case Rep, 2024, 19(8): 3569-3573.
[11] YOKOYA S, NISHII S, TAKEZAWA H, et al. Organized Chronic Subdural Hematoma Treated with Middle Meningeal Artery Embolization and Small Craniotomy. Two Case Reports [J]. Asian J Neurosurg, 2020, 15(2): 421-424.
[12] TAN Yun, SONG Yi, WU Yao, et al. Standardized middle meningeal artery embolization for high-risk recurrent chronic subdural hematoma [J]. China Standardization, 2023, (24): 290-293.
[13] ZHENG He, XIA Xiaolong, ZHANG Meibiao, et al. Middle meningeal artery embolization for recurrent chronic subdural hematoma in 17 cases [J]. Zhejiang Surgery of Trauma, 2023, 28(11): 2042-2045.
[14] HIRAI S, ONO J, ODAKI M, et al. Embolization of the Middle Meningeal Artery for Refractory Chronic Subdural Haematoma. Usefulness for Patients under Anticoagulant Therapy [J]. Interv Neuroradiol, 2004, 10 Suppl 2(Suppl 2): 101-104.
[15] MORDEN F T C, CABALLERO C G, ABELLA M, et al. Middle meningeal artery embolization for symptomatic chronic subdural hematoma in the setting of severe transfusion-refractory thrombocytopenia: a case study and review of the literature [J]. Surg Neurol Int, 2023, 14: 223.
[16] YAJIMA H, KANAYA H, OGINO M, et al. Middle meningeal artery embolization for chronic subdural hematoma with high risk of recurrence: a single institution experience [J]. Clin Neurol Neurosurg, 2020, 197: 106097.
[17] SHAPIRO M, WALKER M, CARROLL K T, et al. Neuroanatomy of cranial dural vessels: implications for subdural hematoma embolization [J]. J Neurointerv Surg, 2021, 13(5): 471-477.
[18] VAIDYA S, TOZER K R, CHEN J. An overview of embolic agents [J]. Semin Intervent Radiol, 2008, 25(3): 204-215.
[19] ELLENS N R, SCHARTZ D, KOHLI G, et al. Safety and efficacy comparison of embolic agents for middle meningeal artery embolization for chronic subdural hematoma [J]. J Cerebrovasc Endovasc Neurosurg, 2024, 26(1): 11-22.
[20] FIORELLA D, HIRSCH J A, ARTHUR A S. Embolization of the middle meningeal artery for the treatment of chronic subdural hematoma: considerations for pragmatic trial design [J]. J Neurointerv Surg, 2021, 13(4): 295-297.
[21] SCOVILLE J, JOYCE E, TAUSSKY P, et al. Primary middle meningeal artery embolization for non-acute subdural hematoma: a multi-institutional retrospective review of particle versus liquid embolic agents [J]. Neurosurgery, 2020, 67.
[22] AGGIPOTHU B, DEEPALAM S, BADACHI S, et al. Middle Meningeal Artery Embolization for the Management of Chronic Subdural Hematoma [J]. Cureus, 2023, 15(10): e47293. 
[23] ORSCELIK A, SENOL Y C, BILGIN C, et al. Middle meningeal artery embolization without surgical evacuation for chronic subdural hematoma: a single- center experience of 209 cases [J]. Front Neurol, 2023, 14: 1222131.

Subscription
E-Mail Alert
Most popular papers
Call for Special Issue
Publication Ethics & OA Statement
Plagiarism Policy
Contact Us
Downloads: 7662
Visits: 405419

Sponsors, Associates, and Links

All published work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright © 2016 - 2031 Clausius Scientific Press Inc. All Rights Reserved.